Ozgur Selim Ser

Ozgur Selim Ser

Auto-generated profile, based on publicly available information

Ozgur Selim Ser

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation Abbott Northwestern Hospital Minneapolis Minnesota USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2021 in The Egyptian Heart Journal
Verified
Journal Article
Open access
PDF file
ÖSÖzgür Selim Ser
Özgür Selim Ser
GÇGökhan Çetinkal
Gökhan Çetinkal
OKOnur Kiliçarslan
Onur Kiliçarslan
YDYalçın Dalgıç
Yalçın Dalgıç
SBServet Batit
Servet Batit
ZYZerrin Yiğit
Zerrin Yiğit
Background: Coronary artery ectasia (CAE) is described as the enlargement of a coronary artery segment by 1.5 times or more, which is generally associated with the atherosclerotic process. Atherosclerotic changes lead to arterial remodeling result in CAE. In our study, we measured serum transforming growth factor (TGF)-β1 levels, which have a protective role against atherosclerosis. Further, we aimed to assess the TGF-β1 gene variants rs1800469 (–509C>T, c.−1347C>T) and rs1800470 (c.+29T>C, p.Pro10Leu, rs1982073), which might have an effect on TGF production. Overall, 2877 patients were screened including 56 patients with CAE and 44 patients with normal coronary arteries who were included in the study. Serum TGF-β1 levels were measured using ELISA and compared between two groups. Additionally, TGF-β1 rs1800469 and rs1800470 gene variations were determined using TaqMan® SNP Genotyping Assays. Results: Serum TGF-β1 levels were significantly lower in patients with CAE than in controls (p=0.012). However, there was no difference in terms of the genotype and allele distributions of TGF-β1 rs1800469 and rs1800470 polymorphisms. Serum TGF-β1 levels were higher in individuals carrying the TGF-β1 rs1800470 G allele (GG+AG) than in individuals with normal homozygous AA genotype in the CAE group (p=0.012). Conclusion: Our findings suggest that lower serum TGF-β1 levels are associated with an increased risk for CAE development and that TGF-β1 polymorphisms exert a protective effect. Furthermore, TGF-β1 rs1800470 G allele carriers were shown to have higher TGF-β1 levels in the CAE group. This suggests that having the G allele in the TGF-β1 rs1800470 polymorphism could prevent CAE development.

3 December 2022 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
KPKubra Cigdem Pekkoc-Uyanik
Kubra Cigdem Pekkoc-Uyanik
EAEzgi Irmak Aslan
Ezgi Irmak Aslan
OKOnur Kilicarslan
Onur Kilicarslan
OSOzgur Selim Ser
Ozgur Selim Ser
SOSerhan Ozyildirim
Serhan Ozyildirim
HYHulya Yilmaz-Aydogan
Hulya Yilmaz-Aydogan

13 October 2025 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
DMDeniz Mutlu
Deniz Mutlu
ARAthanasios Rempakos
Athanasios Rempakos
DSDimitrios Strepkos
Dimitrios Strepkos
PCPedro E. P. Carvalho
Pedro E. P. Carvalho
MAMichaella Alexandrou
Michaella Alexandrou
SGSevket Gorgulu
Sevket Gorgulu

30 August 2024 in Angiology
Verified
Journal Article
Closed access
ÖSÖzgür Selim Ser
Özgür Selim Ser
KKKudret Keskin
Kudret Keskin
GÇGökhan Çetinkal
Gökhan Çetinkal
BKBetül Balaban Kocaş
Betül Balaban Kocaş
HKHakan Kilci
Hakan Kilci
KKKadriye Kılıçkesmez
Kadriye Kılıçkesmez
The Atherogenic Index of Plasma (AIP) is associated with coronary artery disease (CAD) and acute coronary syndrome (ACS), but the relationship between AIP and ACS in elderly patients remains unclear. We investigated the prognostic capability of AIP for in-hospital and long-term mortality in elderly patients with ACS undergoing coronary angiography (CA). We analyzed 627 patients with ACS over 75 years of age who were admitted to our clinic between April 2015 and December 2022 and underwent CA. The primary clinical endpoints were in-hospital, 30-day, 1-year, and long-term mortality. The median follow-up time was 27 months. AIP was defined as log (triglyceride/high-density lipoprotein cholesterol). In-hospital mortality rates for patients with AIP ≤.1 and AIP >.1 were 4.7% and 17.6% ( P < .001), 30-day mortality rates were 8.7% and 32.2% ( P = .01), 1-year mortality rates were 12.1% and 45.1% ( P < .001), and long-term mortality rates were 47.3% and 67.5% ( P < .001), respectively. Multivariate Cox regression analysis revealed AIP, age, left ventricle ejection fraction (LVEF), admission creatinine, and Killip ≥2 as independent predictors for long-term mortality. AIP can predict in-hospital and long-time all-cause mortality in elderly patients with ACS undergoing CA. Age, LVEF, admission creatinine, and Killip ≥2 are additional factors that predict long-term all-cause mortality.

1 July 2022 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
GCGokhan Cetinkal
Gokhan Cetinkal
BKBetul Balaban Kocas
Betul Balaban Kocas
KKKudret Keskin
Kudret Keskin
HKHakan Kilci
Hakan Kilci
OSOzgur Selim Ser
Ozgur Selim Ser
KKKadriye Kilickesmez
Kadriye Kilickesmez
Coronary bifurcation lesions,POT-side-POT,kissing balloon inflation,single- stent strategy

29 March 2022 in Angiology
Verified
Journal Article
Closed access
KKKudret Keskin
Kudret Keskin
SSSerhat Sığırcı
Serhat Sığırcı
AGAhmet Gürdal
Ahmet Gürdal
ÖSÖzgür S. Ser
Özgür S. Ser
HKHakan Kilci
Hakan Kilci
ÖAÖmer Alyan
Ömer Alyan
Despite implementation of new interventional techniques and therapeutic advances, elderly patients with acute coronary syndrome (ACS) continue to be susceptible to in-hospital bleeding compared with younger ones. Thus, we investigated the incidence of in-hospital bleeding events and associated risk factors in elderly (≥ 75°years) ACS patients. We also wanted to define the bleeding sites, characteristics, and associated mortality. Bleeding Academic Research Consortium (BARC) classification type 2, 3, or 5 was used to define bleeding events. Overall, 539 patients were included in the study (mean age: 82.5 ± 4.8°years; 282 (52.3%) females). Of these patients, 69 (12.8%) developed in-hospital bleeding. Factors that were independently related with in-hospital bleeding were age (odds ratio (OR): 1.08; 95% confidence interval (CI): 1.011.14, P = .01), acute kidney injury (OR: 3.66; 95% CI: 2.016.69; P < .01), tirofiban (OR: 4.43; 95% CI: 1.7810.99; P < .01), and ticagrelor (OR: 1.93; 95% CI: 1.013.73; P = .04) administration. The urinary tract was the most frequent bleeding site, followed by femoral arteries. In conclusion, ticagrelor and tirofiban should be used with caution in elderly ACS patients.